SAKAR HEALTHCARE LIMITED Financial Ratios
SAKAR · Healthcare · Current price ₹991
P/E ratio
72.3x
P/B ratio
6.1x
ROE
6.1%
ROCE
8.5%
Debt / Equity
0.22
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 72.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 6.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 6.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 8.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.22 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SAKAR HEALTHCARE LIMITED's latest numbers.
SAKAR HEALTHCARE LIMITED profitability
SAKAR HEALTHCARE LIMITED generates a return on equity of 6.1% and a return on capital employed of 8.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.22 and a P/E of 72.3x, SAKAR HEALTHCARE LIMITED is conservatively financed. Our overall business-quality score for the company is 4.9 / 10.
Understand the ratios
More on SAKAR HEALTHCARE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.